Please select the option that best describes you:
Would you consider neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer who are cisplatin-ineligible?
If so, what chemotherapy regimen would you use? If not, what management options would you generally recommend?
Answer from: Medical Oncologist at Academic Institution
We have level 1 evidence supporting neoadjuvant cisplatin-based chemotherapy followed by cystectomy, there is no evidence supporting non-cisplatin based chemotherapy. Patients unfit for cisplatin should proceed directly to surgery
Sign In or Register to read more
Answer from: Medical Oncologist at Academic Institution
Prior to 2025, the answer to this question would be no in the United States. Cisplatin was considered the most active drug to include in neoadjuvant therapy of MIBC prior to radical cystectomy, and for patients who were not eligible to receive it due to medical conditions or renal function, or refus...